A. Scardina

A phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis.

L. Dawson, A. Chen, M. Zahurak, 2014 .

Integrating Palliative Care for Patients on Clinical Trials: Opportunities for Oncology Nurses

Thomas J. Smith, B. Ferrell, T. Borneman, 2020, Asia-Pacific Journal of Oncology Nursing.

Phase I Trial of Vorinostat Combined with Cytarabine and Etoposide in Patients (pts) with Advanced Acute Leukemia and High-Risk Myelodysplastic Syndromes

M. Tan, M. Egorin, I. Gojo, 2008 .

Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study

G. Rosner, K. Kelly, M. Carducci, 2020, Clinical Cancer Research.

A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis

L. Dawson, A. Chen, M. Zahurak, 2014, Clinical Cancer Research.

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers.

L. Dawson, A. Chen, M. Zahurak, 2016, Gynecologic oncology.